Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5362_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Carbon Based Nanomaterials for Drug Delivery
- •Preface
- •Acknowledgements
- •Contents
- •Editor and Contributors
- •Abbreviations
- •1.2 Market Statistics
- •Carbon-Based Nanomaterials: An Overview
- •1. Introduction
- •1.1 Evolution of Carbon-Based Nanomaterials
- •2. Carbon-Based Nanostructures
- •2.1 Fullerene
- •2.2 Carbon Nanotubes (CNTs)
- •2.4 Graphene
- •2.5 Nanodiamonds (NDs)
- •2.6 Nano-Onions (CNOs)
- •2.7 Nanohorns (CNHs)
- •2.8 Carbon Dots (CDs)
- •2.9 Nanoporous Activated Carbon
- •3. Synthesis Techniques
- •4. Properties of Carbon-Based Nanomaterials
- •4.1 Physicochemical Properties
- •4.2 Thermal Properties
- •4.3 Mechanical Properties
- •4.4 Optoelectronic Properties
- •4.5 Antimicrobial Properties
- •4.6 Biological Properties
- •5. Applications of Carbon-Based Nanomaterials
- •5.1 Environmental Remediation
- •5.2 Agriculture
- •5.3 Biofuel
- •5.4 Energy Storage
- •5.5 Biomedical Applications
- •6. Challenges and Future Perspectives
- •7. Concluding Remarks
- •References
- •Carbon-Based Nanostructured Materials: Designing, Properties and Applications
- •1. Introduction
- •2.1 Zero-Dimensional Carbon-Based Nanostructures (0D)
- •2.2 One-Dimensional Carbon-Based Nanostructures
- •2.3 Two-Dimensional (2D) Carbon-Based Nanostructures
- •2.4 Three-Dimensional (3D) Carbon-Based Nanostructures
- •3.1 Chemical Vapor Deposition
- •3.2 Hydrothermal and Solvothermal Techniques
- •3.3 Microwave-Assisted Technique
- •3.4 Chemical Oxidation Synthesis
- •4. Properties of Carbon-Based Nanostructured Materials
- •4.1 Thermal Properties
- •4.2 Mechanical Properties
- •4.3 Optoelectronic Properties
- •4.4 Antimicrobial Properties
- •4.5 Biological Properties
- •5. Applications of Carbon-Based Nanostructured Materials
- •5.2 Antibacterial and Antiviral Applications
- •5.3 Theragnostic
- •5.4 Wound Healing
- •5.5 Tissue Engineering
- •5.6 Drug Delivery
- •5.7 Biosensing
- •6. Challenges and Future Perspectives
- •7. Concluding Remarks
- •References
- •Drug Delivery System and Technologies
- •1. Introduction
- •2. Drug Delivery System
- •2.1 Conventional Drug Delivery System
- •2.2 Advanced Drug Delivery System
- •2.3 Controlled and Sustainable Drug Delivery System
- •3. Drug Delivery Technologies
- •3.1 Active and Passive Drug Delivery
- •3.2 Smart Drug Delivery
- •3.3 Intravenous and Extravaneous Drug Delivery
- •3.4 Various Types of Delivery Technologies
- •4. Challenges and Future Perspectives
- •5. Conclusion
- •References
- •Carbon-Based Nanomaterials for Drug Delivery: Past, Present, Future Directions
- •1. Introduction
- •3. Current Status in Drug Delivery by CNMs
- •3.1 Graphene-Based Nanomaterials in Drug Delivery
- •3.4 Nanodiamond Based Drug Delivery Systems
- •3.5 Nano-Onions in Drug Delivery
- •3.6 Nanohorns in Drug Delivery
- •3.7 Fullerene in Drug Delivery
- •4. Challenges and Future Perspective
- •5. Conclusions
- •References
- •Carbon Nanomaterial-Incorporated Supramolecular Drug Delivery
- •1. Introduction
- •2. Different Carbon Nanomaterials in Drug Delivery
- •2.1 Carbon Nanotubes (CNTs)
- •2.3 Graphene
- •2.4 Carbon Quantum Dots
- •2.5 Fullerene
- •2.6 Carbon Nanohorns
- •2.7 Carbon Nano-Onions
- •2.8 Nano-Diamond
- •3. Supramolecular Chemistry in Drug Delivery
- •3.1 Principles of Supramolecular Chemistry
- •3.3 Applications of Supramolecular Biomaterials
- •4. Carbon Nanomaterial-Incorporated Supramolecular Drug Delivery
- •5.1 Cyclodextrins
- •5.2 Calixarenes
- •5.3 Cucurbituril
- •5.4 Pillarenes
- •5.5 Crown Ether
- •6. Toxicity Concerns of Carbon Nanomaterials
- •7. Improving the Effectiveness of Nanoparticle Systems
- •8. Future of Nanomedicine
- •9.1 Challenges
- •9.2 Future Perspectives and Opportunities
- •9.3 Conclusions
- •References
- •Carbon Nanomaterial-Based Polymeric Nanocomposites for Drug Delivery
- •1. Introduction
- •2.1 Carbon Quantum Dot-Based Polymer Nanocomposite
- •2.2 Carbon Nanotube-Based Polymer Nanocomposite
- •2.3 Graphene Quantum Dot-Based Polymer Nanocomposite
- •2.5 Fullerene-Based Polymer Nanocomposite
- •2.6 Nanodiamond-Based Polymer Nanocomposite
- •3. Drug Delivery Systems Using Carbon Nanomaterial
- •3.1 Anticancer Drug Delivery
- •3.3 Infectious Disease Drug Delivery
- •3.4 Topical Drug Delivery
- •3.5 Brain Drug Delivery
- •3.6 Oral Drug Delivery
- •4. Challenge and Future Perspectives
- •5. Conclusion
- •References
- •Carbon Nanomaterial-Incorporated Polysaccharide-Based Nanocomposite for Drug Delivery
- •1. Introduction
- •1.1 Drug Delivery
- •1.2 Carbon Nanomaterials
- •1.3 Polysaccharide-Based Nanocomposite
- •2.1 CN-Incorporated Alginate-Based Nanocomposite
- •2.2 CN-Incorporated Cellulose-Based Nanocomposite
- •2.3 CN-Incorporated Chitosan-Based Nanocomposite
- •2.4 CN-Incorporated Dextran-Based Nanocomposite
- •2.5 CN-Incorporated Hyaluronic Acid-Based Nanocomposite
- •2.6 CN-Incorporated Starch-Based Nanocomposite
- •2.7 CN-Incorporated Pectin-Based Nanocomposite
- •2.8 CN-Incorporated Guar Gum-Based Nanocomposite
- •2.9 CN-Incorporated Agarose-Based Nanocomposite
- •2.10 CN-Incorporated Carrageenan-Based Nanocomposite
- •2.11 CN-Incorporated Glucomannan-Based Nanocomposite
- •3. Challenges and Future Prospective
- •4. Concluding Remarks
- •References
- •Graphene-Based Nanomaterials for Drug Delivery
- •1. Introduction
- •1.1 Challenges in Conventional Drug Delivery Systems
- •1.2 Overview of Nanomaterials for Drug Delivery
- •1.3 Role of Graphene-Based Nanomaterials in Drug Delivery
- •2. Synthesis of Graphene
- •2.1 Chemical Reduction Method
- •2.2 Thermal Reduction
- •2.3 Electrochemical Reduction
- •2.4 Chemical Vapor Deposition Method
- •2.5 Mechanical Exfoliation
- •2.6 Epitaxial Growth Method
- •2.7 Growth in Solvothermal and Hydrothermal Systems
- •2.8 Electrochemical Deposition
- •3. Types of Graphene-Based Materials
- •3.1 Graphene Quantum Dots, (GQDs)
- •3.2 Graphene Oxide (GO)
- •3.3 Graphene Nanoribbons (GNRs)
- •3.4 Oxidized Graphene Nanoribbons
- •4. Graphene Functionalized Materials for Drug Delivery
- •4.1 In Bone Tissue Regeneration
- •4.2 In Neural Regeneration
- •4.3 In Photodynamic and Photothermal Therapy
- •4.4 In Enhancing Cellular and Humoral Immunity
- •4.6 Miscellaneous
- •5. Challenges and Future Perspective
- •6. Conclusion
- •References
- •Carbon Quantum Dots Based Materials for Drug Delivery
- •1. Introduction
- •2. Synthesis Process of Carbon Quantum Dots
- •2.1 Top-Down Approaches
- •2.2 Bottom-Up Approaches
- •2.3 Microwave-Assisted Method
- •2.4 Electrochemical Method
- •2.5 Laser Ablation Method
- •2.6 Pyrolysis Method
- •2.7 Template-Assisted Method
- •4. Challenges and Future Perspective
- •5. Concluding Remarks
- •References
- •Carbon-based Nanocarriers for Sustained Drug Release in Dentistry
- •1. Introduction
- •2.1 Oral Mucosa Structure
- •2.2 Sites for Drug Delivery
- •2.3 Permeability
- •3. Local Drug Delivery for Dental Diseases
- •3.1 Odontogenic Infection
- •3.2 Non-odontogenic Infection
- •4. Bio-adhesive Nanoparticles: Novel Treatment Modality
- •4.1 Bio-adhesive Nanoparticles
- •4.2 Mechanism of Bioadhesion
- •5.1 Carbon Nanotubes
- •5.2 Graphene
- •5.3 Nanodiamonds
- •5.4 Fullerenes
- •5.5 Porous Carbon
- •5.6 Carbon Dots
- •6. Drug Delivery Systems Based on CBNs
- •6.2 Immediate Drug Delivery System (IDDS)
- •6.3 Sustained-release Drug Delivery Systems
- •6.4 Controlled Drug Delivery System (CDDs)
- •8. Conclusion
- •References
- •Fullerene Based Materials for Drug Delivery
- •1. Introduction
- •2. Types of Fullerene Derivatives
- •2.1 Exohedral Fullerene Derivatives
- •2.2 Endohedral Fullerene Derivatives
- •2.3 Surface Derivatized Fullerenes
- •3. Interaction of Fullerene Derivatives for Drug Delivery
- •4. Fullerene Based Materials for Drug Delivery
- •4.1 Nucleic Acid Delivery
- •4.2 Peptide Delivery
- •4.3 Topical Drug Delivery
- •4.4 Infectious Diseases Drug Delivery
- •4.5 Anticancer Drug Delivery
- •4.7 Brain Drug Delivery
- •4.8 Ocular Drug Delivery
- •5. Challenges and Future Perspectives
- •6. Concluding Remarks
- •6.1 Abbreviations
- •References
- •Graphene Quantum Dots-based Nanomaterials for Drug Delivery
- •1. Introduction
- •2. Synthesis of GQDs
- •3. GQD’s Properties for Drug Delivery
- •3.1 Optical Properties
- •3.2 Physicochemical Properties
- •3.3 Mechanical Properties
- •3.4 Biocompatibility and Cytotoxicity
- •4. Characterization of GQDs-Based Nanomaterials
- •4.1 Characterization of Multifunctional GQDs-Based Nanomaterials
- •5.1 Strategies for Developing Medication Delivery Systems Based on GQD
- •5.2 PH-responsive Drug Delivery Systems (GQD-DDSs)
- •5.3 Targeted Drug Delivery Using Ligand-Based GQDs as a Mediator
- •5.4 Improvement of Medicines’ Pharmacological Properties Using GQDs
- •5.5 Enhancing Cytotoxicity with GQD-DDS
- •7. Applications of Chiral GQDs
- •10. Challenges and Future Perspectives
- •11. Conclusions
- •References
- •Carbon Nano-onions for Drug Delivery
- •1. Introduction
- •2. Carbon Nano-Onion: A Multi-Layered Nanocarrier
- •3. Synthesis of Carbon Nano-Onions
- •3.1 Annealing Method
- •3.2 Carbon Ion Implantation Method
- •3.3 Arc Discharge Method
- •3.4 Carbon Vapour Deposition Method
- •3.5 Pyrolysis Method
- •6. Carbon Nano-Onions in Drug Delivery
- •6.1 Delivery of Therapeutic Agents
- •6.2 Delivery of Targeting Agents
- •6.3 Delivery of Imaging Agents
- •7. Challenges and Future Perspectives
- •8. Concluding Remarks
- •References
- •Chitosan/Carbon Nanocomposites in Drug Delivery and Cardiovascular Diseases
- •1. Introduction
- •1.1 Drug Delivery
- •1.2 Cardiovascular Diseases
- •1.3 Chitosan and Its Properties
- •1.4 Chitosan/Carbon Nanocomposites
- •2. Chitosan/Carbon Nanocomposites in Drug Delivery
- •3. Chitosan/Carbon Nanocomposites in CVDs
- •3.1 Chitosan-Based Scaffolds
- •3.2 Chitosan in Cardiac Tissue Engineering
- •3.3 Chitosan-Based Cell Therapy
- •3.4 Chitosan-Based Gene Delivery
- •3.5 Chitosan-Protein Interaction
- •4. Challenges and Future Perspective
- •5. Concluding Remarks
- •References
- •Graphene Reinforced Chitosan Nanocomposites for Drug Delivery
- •1. Introduction
- •2. Chitosan: Structure and Properties
- •3. Graphene: Structure, Types and Properties
- •4.1 Electrospinning Method
- •4.2 Sol–gel Method
- •4.3 Solution Mixing Method
- •4.4 In-situ Polymerization Method
- •5.2 Chitosan/Graphene Aerogels
- •5.3 Chitosan/Graphene Hydrogels
- •5.4 Chitosan/Graphene Thin Films
- •6.1 Oral Drug Delivery
- •6.2 Mucosal Drug Delivery
- •6.3 Transdermal Drug Delivery
- •6.4 Parenteral Drug Delivery
- •7. Challenges and Future Perspectives
- •8. Concluding Remarks
- •References
- •1. Introduction
- •2. Functionalization of CNFs
- •2.1 The Need for Functionalization

Carbon Nanomaterial-Incorporated Supramolecular Drug Delivery 165
37. Lacerda L, Russier J, Pastorin G, Herrero MA, Venturelli E, Dumortier H, Jamal KTA, Prato
M, Kostarelos K, Bianco A (2012) Translocation mechanisms of chemically functionalised
carbon nanotubes across plasma membranes. Biomater 33(11):3334–3343
38. Liu X, Tao H, Yang K, Zhang S, Lee ST, Liu Z (2011) Optimization of surface chemistry
on single-walled carbon nanotubes for in vivo photothermal ablation of tumors. Biomater
32(1):144–151
39. Boncel S, Zaj¸ac P, Koziol KKK (2013) Liberation of drugs from multi-wall carbon nanotube
carriers. J Control Release 169(1–2):126–140
40. Zhang W, Zhang Z, Zhang Y (2011) The application of carbon nanotubes in target drug
delivery systems for cancer therapies. Nanoscale Res Lett 6:1–22
41. Baker RTK (2016) Carbon nanofibers. Mater Sci Eng
42. Al-Saleh MH, Sundararaj U (2011) Review of the mechanical properties of carbon nanofiber/
polymer composites. Compos A Appl Sci 42(12):2126–2142
43. Joshi A, Sharma K, Nayyar H, Dharamvir K, Verma G (2019) Encapsulation of carbon
nanofiber inside liposome for target drug delivery. In: AIP conference proceedings. American
Institute of Physics Inc.
44. Gillies RJ, Schabath MB (2020) Radiomics improves cancer screening and early detection.
Cancer Epidemiol Biomarkers Prev 29(12):26–2567
45. Debnath SK, Srivastava R (2021) Drug delivery with carbon-based nanomaterials as versatile
nanocarriers: progress and prospects. Front Nanotechnol 3
46. Soldano C, Mahmood A, Dujardin E (2010) Production, properties and potential of graphene.
Carbon 48(8):2127–2150
47. Abergel DSL, Apalkov V, Berashevich J, Ziegler K, Chakraborty T (2010) Properties of
graphene: a theoretical perspective. Adv Phys 9(4):261–482
48. Goenka S, Sant V, Sant S (2014) Graphene-based nanomaterials for drug delivery and tissue
engineering. J Control Release 173(1):75–88
49. Wang Y, Hu A (2014) Carbon quantum dots: synthesis, properties and applications. J Mater
Chem C Mater 2(34):6921–6939
50. Huang S, Li W, Han P, Zhou X, Cheng J, Wen H, Xue W (2019) Carbon quantum dots:
synthesis, properties, and sensing applications as a potential clinical analytical method. Anal
Methods 11(17):2240–2258
51. Nair A, Haponiuk JT, Thomas S, Gopi S (2020) Natural carbon-based quantum dots and their
applications in drug delivery: a review. Biomed Pharmacother 132
52. Yadav BC, Kumar R (2008) Structure, properties and applications of fullerenes
53. Kazemzadeh H, Mozafari M (2019) Fullerene-based delivery systems. Drug Discov Today
24(3):898–905
54. Nimibofa A, Newton EA, Cyprain AY, Donbebe W (2018) Fullerenes: synthesis and
applications. J Mater Sci 7(3):22
55. Zhu S, Xu G (2010) Single-walled carbon nanohorns and their applications. Nanoscale
2(12):2538–2549
56. Zhang Z, Han S, Wang C, Li J, Xu G (2015) Single-walled carbon nanohorns for energy
applications. Nanomater 5(4):1732–1817
57. Karousis N, Suarez-Martinez I, Ewels CP, Tagmatarchis N (2016) Structure, properties,
functionalization, and applications of carbon nanohorns. Chem Rev 116(8):4850–4883
58. Tagmatarchis N, Maigné A, Yudasaka M, Iijima S (2006) Functionalization of carbon
nanohorns with azomethine ylides: towards solubility enhancement and electron-transfer
processes. Small 2(4):490–494
59. Mykhailiv O, Zubyk H, Plonska-Brzezinska ME (2017) Carbon nano-onions: unique carbon
nanostructures with fascinating properties and their potential applications. Inorganica Chim.
Acta. 468:49–66
60. Palkar A, Melin F, Cardona CM, Elliott B, Naskar AK, Edie DD, Kumbhar A, Echegoyen
L (2007) Reactivity differences between Carbon Nano Onions (CNOs) prepared by different
methods. Chem Asian J 2(5):625–633

166 N. T. Tuli et al.
61. Baidakova M, Vul A (2007) New prospects and frontiers of nanodiamond clusters. J Phys D
Appl Phys 40(20):6300–6311
62. Schrand AM, Hens SAC, Shenderova OA (2009) Nanodiamond particles: properties and
perspectives for bioapplications. Crit Rev Solid State Mater Sci 34(1–2):18–74
63. Guo DS, Liu Y (2014) Supramolecular chemistry of p -Sulfonatocalix[n] arenes and its
biological applications. Acc Chem Res 47(7):1925–1934
64. Albrecht M (2007) Supramolecular chemistry - General principles and selected examples
from anion recognition and metallosupramolecular chemistry. Sci Nat 94(12):951–966
65. Beletskaya I, Tyurin VS, Tsivadze AY, Guilard R, Stern C (2009) Supramolecular chemistry
of metalloporphyrins. Chem Rev 109(5):1659–1713
66. Mali KS, Pearce N, De Feyter S, Champness NR (2017) Frontiers of supramolecular chemistry
at solid surfaces. Chem Soc Rev 46(9):2520–2542
67. Alberti S, Soler-Illia GJAA, Azzaroni O (2015) Gated supramolecular chemistry in hybrid
mesoporous silica nanoarchitectures: controlled delivery and molecular transport in response
to chemical, physical and biological stimuli. Chem Comm 51(28):6050–6075
68. Cui H, Xu B (2017) Supramolecular medicine. Chem Soc Rev 46(21):6430–6432
69. Gerasko OA, Samsonenko DG, Fedin VP (2002) Supramolecular chemistry of cucurbiturils.
Russ Chem Rev 71(9):859–861
70. Steed JW, Turne DR, Wallace KJ (2007) Core concepts in supramolecular chemistry and
nanochemistry
71. Li X, Xu W, Xin Y, Yuan J, Ji Y, Chu S, Liu J, Luo Q (2021) Supramolecular polymer
nanocomposites for biomedical applications. Polym 13:513
72. Xing P, Zhao Y (2018) Supramolecular vesicles for stimulus-responsive drug delivery. Small
Methods 2(4):1–16
73. Paolino D, Cosco D, Molinaro R, Celia C, Fresta M (2011) Supramolecular devices to improve
the treatment of brain diseases. Drug Discov Today 16(7–8):311–324
74. Hudalla GA, Sun T, Gasiorowski JZ, Han H, Tian YF, Chong AS, Collier JH (2014) Gradated
assembly of multiple proteins into supramolecular nanomaterials. Nat Mater 13(8):829–836
75. Zhang Z, Shi L, Wu C, Su Y, Qian J, Deng H, Zhu X (2017) Construction of a supramolecular
drug-drug delivery system for non-small-cell lung cancer therapy. ACS Appl Mater Interfaces
9(35):29505–29514
76. Saptaji K (2018) Machining of biocompatible materials: a review. Int J Adv Manuf Technol
97:22–2292
77. Liu J, Gaynor AT, Chen S, Kang Z, Suresh K, Takezawa A, Li L, Kato J, Tang J, Wang CCL,
Cheng L, Liang X, To AC (2018) Current and future trends in topology optimization for
additive manufacturing. Struct Multidiscipl Optim 57(6):457–2483
78. Kolesnichenko IV, Anslyn EV (2017) Practical applications of supramolecular chemistry.
Chem Soc Rev 46(9):2385–2390
79. Nnebe IM, Schneider JW (2007) Dynamic atomic force microscopy studies to characterize
heterogeneous surfaces. Dekker Encycl Nanosci Nanotechnol 10(1):987–1000
80. Li J, Li M, Tian L, Qiu Y, Yu Q, Wang X, Guo R, He Q (2020) Facile strategy by hyaluronic
acid functional carbon dot-doxorubicin nanoparticles for CD44 targeted drug delivery and
enhanced breast cancer therapy. Int J Pharm 578(17):119122
81. Li Y, Niu Y, Zhu J, Gao C, Xu Q, He Z, Chen D, Xu M, Liu Y (2020) Tailor-made legumain/
pH dual-responsive doxorubicin prodrug-embedded nanoparticles for efficient anticancer drug
delivery and: in situ monitoring of drug release. Nanoscale 12(4):2673–2685
82. Shahabi M, Raissi H (2020) Payload delivery of anticancer drug Tegafur with the assistance of
graphene oxide nanosheet during biomembrane penetration: molecular dynamics simulation
survey. Appl Surf Sci 517:146186
83. Yang J, Su H, Sun W, Cai J, Liu S, Chai Y, Zhang C (2018) Dual chemodrug-loaded singlewalled carbon nanohorns for multimodal imaging-guided chemo-photothermal therapy of
tumors and lung metastases. Theranostics 8(7):1966–1984

Carbon Nanomaterial-Incorporated Supramolecular Drug Delivery 167
84. Oskoueian A, Amin Matori K, Bayat S, Oskoueian E, Ostovan F, Toozandehjani M (2018)
Fabrication, characterization, and functionalization of single-walled carbon nanotube conjugated with tamoxifen and its anticancer potential against human breast cancer cells. J
Nanomater (2018)
85. Sobhani Z, Behnam MA, Emami F, Dehghanian A, Jamhiri I (2017) Photothermal therapy of
melanoma tumor using multiwalled carbon nanotubes. Int J Nanomed 12:4509–4517
86. Ko NR, Nafiujjaman M, Lee JS, Lim HN, Lee YK, Kwon IK (2017) Graphene quantum dotbased theranostic agents for active targeting of breast cancer. RSC Adv 7(19):11420–11427
87. Fan Z, Zhou S, Garcia C, Fan L, Zhou J (2017) PH-Responsive fluorescent graphene quantum
dots for fluorescence-guided cancer surgery and diagnosis. Nanoscale 9(15):4928–4933
88. Mahdavi M, Rahmani F,Nouranian S (2016) Molecular simulation of pH-dependent diffusion,
loading, and release of doxorubicin in graphene and graphene oxide drug delivery systems. J
Mater Chem B 4(46):7441–7451
89. Zhao X, Yang L, Li X, Jia X, Liu L, Zeng J, Guo J, Liu P (2015) Functionalized graphene
oxide nanoparticles for cancer cell-specific delivery of antitumor drug. Bioconjug Chem
26(1):128–136
90. Farazi R, Vaezi MR, Molaei MJ, Saeidifar M, Behnam-Ghader AA (2018) Effect of
pH and temperature on doxorubicin hydrochloride release from magnetite/graphene oxide
nanocomposites. Mater Today Proc 5(7):15726–15732
91. Khorsandi Z, Borjian-Boroujeni M, Yekani R, Varma RS (2021) Carbon nanomaterials
with chitosan: a winning combination for drug delivery systems. J Drug Deliv Sci Technol
66:102847
92. Tiwari H, Karki N, Pal M, Basak S, Verma RK, Bal R, Kandpal ND, Bisht G, Sahoo NG
(2019) Functionalized graphene oxide as a nanocarrier for dual drug delivery applications:
the synergistic effect of quercetin and gefitinib against ovarian cancer cells. Colloids Surf B:
Biointerfaces 178:452–459
93. Pulingam T, Thong KL, Appaturi JN, Nordin NI, Dinshaw IJ, Lai CW, Leo BF (2020) Synergistic antibacterial actions of graphene oxide and antibiotics towards bacteria and the toxicological effects of graphene oxide on human epidermal keratinocytes. Eur J Pharm Sci
142:105087
94. Sharma SK, Saxena KK, Kumar KB, Kumar N (2022) The effect of reinforcements on the
mechanical properties of AZ31 composites prepared by powder metallurgy: an overview.
Mater Today Proc 56:2293–2299
95. Shabgard M, Khosrozadeh B (2017) Investigation of carbon nanotube added dielectric on the
surface characteristics and machining performance of Ti–6Al–4V alloy in EDM process. J
Manuf Process 25:212–219
96. Mamidi N, Castrejón JV, González-Ortiz A (2020) Rational design and engineering of carbon
nano-onions reinforced natural protein nanocomposite hydrogels for biomedical applications.
J Mech Behav Biomed Mater 104
97. Tovar CDG, Castro JI, Valencia CH, Porras DPN, Hernandez JHM, Valencia ME, Velásquez
JD, Chaur MN (2019) Preparation of chitosan/poly(Vinyl alcohol) nanocomposite films incorporated with oxidized carbon nano-onions (multi-layer fullerenes) for tissue-engineering
applications. Biomol 9(11)
98. Lettieri S, Camisasca A, d’Amora M, Diaspro A, Uchida T, Nakajima Y, Yanagisawa K,
Maekawaf T, Giordani S (2017) Far-red fluorescent carbon nano-onions as a biocompatible
platform for cellular imaging. RSC Adv 7(72):45676–45681
99. Kostarelos K, Bianco A, Prato M (2009) Promises, Facts and challenges for carbon nanotubes
in imaging and therapeutics. Nat Nanotechnol 4(10):627–633
100 Real DA, Bolanos K, Priotti J, Yutronic N, Kogan MK, Sierpe R, Donoso-Gonzalez O
(2021) Cyclodextrin-modified nanomaterials for drug delivery: classification and advances in
controlled release and bioavailability. Pharmaceutics 13(12)
101. An L, Wang JW, Liu JD, Zhao ZM, Song YJ (2019) Design, preparation, and characterization
of novel calix [4] arene bioactive carrier for antitumor drug delivery. Front Chem 7

168 N. T. Tuli et al.
102. Das D, Assaf KI, Nau WM (2019) Applications of cucurbiturils in medicinal chemistry and
chemical biology. Front Chem 7
103. Song N, Lou XY, Ma L, Gao H, Yang YW (2019) Supramolecular nanotheranostics based on
pillarenes. Theranostics 9(11):3075–3093
104. Chehardoli G, Bahmani A (2019) The role of crown ethers in drug delivery. Supramol Chem
31(4):221–238
105. Mishra D, Hubenak JR, Mathur AB (2013) Nanoparticle systems as tools to improve drug
delivery and therapeutic efficacy. J Biomed Mater Res A 101(12):3646–3660
106. Harish V, Tewari D, Gaur M, YadavAB, Swaroop S, Bechelany M, Barhoum A (2022) Review
on nanoparticles and nanostructured materials: bioimaging, biosensing, drug delivery, tissue
engineering, antimicrobial, and agro-food applications. Nanomater 12(3)

Carbon Nanomaterial-Based Polymeric Nanocomposites for Drug Delivery
Danyang Song and Hongbin Li
Abstract As the research on drug delivery systems continues to improve, the use of
carbon nanomaterials in drug delivery is becoming more and more widespread, but
there are limitations to the use of carbon nanomaterials alone in drug systems, so the
use of nano-polymers in combination with carbon nanomaterials is more conducive
to the use of drug delivery, which in the area of drug delivery is mainly used in the
field of anticancer therapy, topical therapies, and the treatment of infectious diseases,
and so on.
·
Keywords Carbon nanomaterials
delivery
Lung-specific drug delivery·Oral drug delivery
·
Abbreviations
Polymer nanocomposite·Anticancer drug
CF Carbon fiber
CNT Carbon nanotube
CQDs Carbon quantum dots
Cur Curcumin
DOX Doxorubicin
FA Folic acid
FCNPs Fluorescent carbon nanoparticles
FGQC Quantum dot/chitosan nanocomposites
GLUT5 Glucose transporter protein
GOM Graphene oxide monomer
IONP Iron oxide nanoparticles
D. Song · H. Li (B)
College of Light Industry and Textile, Qiqihar University, Qiqihar 161000, Heilongjiang, P. R.
China
e-mail: lhb987258@163.com
H. Li
Engineering Research Center for Hemp and Product in Cold Region of Ministry of Education,
Qiqihar University, Qiqihar, P. R. China
169

170 D. Song and H. Li
MIP Molecularly imprinted polymer
MOFs Metal-organic framework
MTX Methotrexate
PB Probucol
PVDF Polyvinylidene fluoride
UCNPs Upconverted nanophosphorites
VEGF Vascular endothelial growth factor
ZIF-8 Zeolite imidazolate framework-8
1 Introduction
With the continuous progress of science and technology, single function and composition of the material has long been unable to meet the growing demand. So, nanoscale
polymer materials were created. Polymer nanomaterials are used in many applications, including building materials [1], batteries [2, 3], glass [4, 5], sensors [6, 7],
etc. This chapter focuses on their use in medicine. At present, there are hundreds
of polymer nanocomposites that have been developed. Polymer nanocomposite is a
kind of nanocomposite, in which when nanomaterial is the dispersed phase and the
organic polymer is continuous phase. Polymer nanocomposite is a new type of material formed by various nano-units and organic polymer materials in various ways, in
which the nano-units can be metal, inorganic, polymer, and many more.
Carbon-based materials mainly refer to the shielding materials made of carbon
fiber (CF), silicon carbide fiber, carbon black, carbon nanotube (CNT), graphene,
and other carbon materials as filling materials. Carbon-based materials take the
aromatic ring structure formed by carbon atoms as their main structural framework, which has the characteristics of large specific surface area, uniform surface
morphology, and developed pore structure. Depending on the dimensions, carbonbased materials can be categorized into four different materials from zero to three
dimensions. Among them, zero-dimensional materials involve carbon quantum dots
(CQDs) and fullerenes, one-dimensional materials encompass carbon fibers and
CNTs, two-dimensional materials include graphene, three-dimensional materials are
also called bulk materials, comprise of all kinds of three-dimensional intrinsic or
composite systems. In a broad sense, carbon-based materials can be regarded as a
material system with carbon atoms as the skeleton, including pure carbon systems like
diamond and graphite and polyatomic systems such as silicon carbide and polymer
organic compounds. Various carbon nanomaterials are illustrated in Fig. 1.

Carbon Nanomaterial-Based Polymeric Nanocomposites for Drug … 171
Fig. 1 Carbon nanomaterials
2 Drug Delivery Systems Using Carbon
Nanomaterial-Based Polymer Nanocomposites
By combining different carbon nanomaterials and polymers, various nanocomposites are utilized in drug delivery system. Carbon nanomaterials mainly introduce
CQDs, CNT, graphene quantum dots, metal–organic framework, fullerenes, and
nanodiamonds. Next, different drug delivery systems will be introduced according
to the classification of carbon nanomaterials. Nano-carbon fillers such as graphene,
graphene oxide, CNT, and metal-based nanoparticles play a pivotal role in the
structure morphology and properties of carbohydrate polymer nanocomposites. The
biocompatibility of polymers incorporating nanoparticles has advanced in numerous
applications such as biosensors, antimicrobials, damage curing, and drug transport.
2.1 Carbon Quantum Dot-Based Polymer Nanocomposite
CQDs were first discovered in 2004 during the washing process of single-walled
CNT [8]. CQDs are emerging categories of carbon-based nanomaterials with many
unique properties and advantages. Due to their size at the nanometer level, carbon
nanodots exhibit significant quantum confinement effects, i.e., their electronic structure and optical properties change significantly. This makes CQDs have tunable
fluorescence properties, such as emission wavelength, luminescence intensity, and
fluorescence lifetime; they also have good photostability, which can maintain their
fluorescence performance under prolonged illumination, and are not easy to fade out
or degrade, which makes them suitable for applications such as long-term tracking
and micro-imaging; and they are biocompatible with better biocompatibility, and
have a lower toxicity to organisms and cells. This makes them have a wide range
of potential applications in the biomedical field, such as biomarkers, drug delivery
and bioimaging, etc. Meanwhile, CQDs are relatively simple to synthesize and can
be prepared by pyrolysis of carbon sources, chemical oxidation or laser stripping.
In addition, their surfaces are easy to be functionalized and modified, and different
functional groups can be introduced through chemical reactions to achieve specific
application requirements.

172 D. Song and H. Li
CQDs have good application prospects in many fields, such as medical imaging
technology m, energy development, etc. The main applications of CQDs in
biomedicine are biomedical imaging, drug delivery, cancer treatment, gene delivery.
This chapter mainly introduces the application of CQDs in drug delivery. On account
of its small size and biocompatibility, CQDs is very suitable to act as a carrier in drug
delivery, and it also has optical properties, so it is very suitable for detection in vivo.
The cytotoxicity of CQDs is the main concern. CQDs cytotoxicity-related research
reports were carried out by different researchers and organizations, and satisfactory
data and research reports were put forward. The utilization of surface hydrophobic
CQDs in combination with hydrophilic polymers is a prerequisite for the preparation
of hydrogels. The hydrophilicity of CQDs is related to the hydroxyl and carboxyl
groups on their surfaces, and they have high water dispersibility and low cytotoxicity.
Researchers synthesized hydroxyapatite/alginate/CQDs (HA/Alg/CQDs)
nanocomposites by coprecipitation method. The synthesized materials have
good dispersion and stability, so they are very suitable for use in bone tissue repair
[9]. Zhai et al. developed a nuclear-targeted gene delivery platform based on fluorescent CQDs. Polyethyleneimine and polyethylene glycol cooperated to passivate
the surface of CQDs, which is expected to be an efficient CRISPR/Cas9 delivery
vector with in vitro imaging traceability [10]. Bao et al. designed and synthesized
a delivery platform with pH-corresponding combination of DOX nanoparticles and
CQDs. The synthesized delivery system has high cellular cytotoxicity against tumor
cells and can enter the cells by endocytosis [11].
2.2 Carbon Nanotube-Based Polymer Nanocomposite
CNT is a very practical nanomaterial, and it is one of the most important nano-carbon
allotropes. CNT is a kind of one-dimensional tubular or cylindrical nanocarbon. It is
just a graphene nanosheet with sp
tronic, optical, electrical, physical, and other mechanical properties. The unique CNT
structure can be categorized into single-walled CNT (SWCNT), double-walled CNT
(DWCNT), and multi-walled CNT (MWCNT). The main synthesis techniques of
CNTs are chemical vapor deposition, arc displacement, and laser deployment. CNTs
have been characterized by interesting properties such as high flexibility, electrical
conductivity, thermal conductivity, mechanical strength, and chemical inertness.
A novel green solvent was prepared from SWCNTs doped with molecularly
imprinted polymer (MIP) nanocomposites using FB as template molecule. The
drug diffusion coefficient produced by SWCNTs reinforced MIP was the lowest
in the kinetic analysis of FB release from all samples. Compared with commercial FB tablets, the relative bioavailability (F%) of SWCNT-MIP composites is the
highest, which is 143.3%. The prepared SWCNT-MIP nanocomposites have the
potential to be used as controlled-release devices [12]. H
media prepared polypyridine/CNT/alginate multifunctional nanocomposites as a
platform for loading metoprolol with a cumulative release of less than 10% after 5 h
2
-bonded carbon atoms. CNT have distinctive elec-
oxidation in micellar
2O2

Carbon Nanomaterial-Based Polymeric Nanocomposites for Drug … 173
under passive conditions. [13]. Magnetic multi-walled carbon nanotube (MMWCNT)
hydrogel materials based on polyacrylic acid grafts are a new potential vehicle for
drug delivery. The diffusion coefficient of the carbo hydrogel and the release mechanism of tetracycline hydrochloride (TCH) were studied. Because the diffusion index
of TCH released from MMWCNTs hydrogel is 0.26, its release mechanism is suitable
for use in drug delivery [14].
2.3 Graphene Quantum Dot-Based Polymer Nanocomposite
GQDs are carbon nanomaterials formed from graphene fragments. Due to their
remarkable fluorescent properties, GQDs have highly adjustable fluorescent properties that can be realized by adjusting parameters such as their size, surface functional
groups, and chemical composition. GQDs have good biocompatibility with living
organisms and do not cause significant toxic reactions. Due to their large specific
surface area and adjustable structural properties, GQDs can be used as efficient
carriers for drugs or other molecules with good loading and release ability. Based on
these properties, it has a wide range of applications in bio-imaging, drug delivery,
and other fields, which provides a good basis for its use in biomedical applications.
Naproxen (NAP) was encapsulated in these pH-sensitive nanoparticles by copolymerization with methacrylic acid in different proportions, which can be used as a
suitable carrier for colon-specific drug delivery [15].
For the first time, MgAl-layered double hydroxide, Mn
GQDs, and polyaniline were combined into a nanocarrier for the intracellular release
of DOX from breast cancer cells, and about 80% of the drug was released in a low
pH environment, exhibiting pH-triggered release characteristics [16]. Polypyrrole/
mesoporous silica (PPy/mSiO
) core–shell nanocomposites were used as nanocar-
2
riers of tumor chemotherapy drug methotrexate (MTX). GQDs were introduced into
the outer surface of PPy/mSiO
. Under the irradiation of NIR light, the caps of the
2
GQDs were removed and the encapsulated MTX was released from the nanocarriers
[17].
An experimental DOX imprinted photoluminescent polymer was developed by a
precipitation radical polymerization strategy using GQDs as pH-responsive nanocarriers. The in vitro drug release to the prepared photoluminescent nanocarriers
exhibited a pH-controlled sustained release behavior. Cytotoxicity studies showed
that the DOX-loaded nanocarriers exhibited significant cytotoxicity against human
lung adenocarcinoma A549 cell line [18, 19]. In summary, GQDs are ideal fillers
for polymer nanocomposites because of their superior physical, electrical, and
thermal properties. In recent years, graphene/polymer nanocomposites have become
a research hotspot for polymer-based nanocomposites.
nanoparticles, N-
3O4

174 D. Song and H. Li
2.4 Metal Organic Framework-Based Polymer
Nanocomposite
MOFs stands for metal–organic skeleton compound. It is self-assembly from a combination of inorganic metal centers and bridging organic ligands. MOFs are a unique
type of material that consists of a metallic framework combined with organically
linked motifs. Their high degree of porosity, flexibility, and the ability to embed
different ligands that confer specific properties make them promising for a wide
range of applications in many fields. In recent years, MOFs have become a potential
drug delivery carrier in biomedical field due to its large specific surface volume, high
porosity, and easy modification. In this paper, the micelles of selenium-containing
polymers containing drugs were encapsulated in a MOFs, and the multi-response
release of DOX was achieved by using selenium-containing polymers with reDOX
triggering properties and MOFs with pH-triggering properties in DDS [20].
Enzymes can also be introduced into MOFs, and some researchers have introduced
active enzymes into ZIF-8 to achieve bactericidal properties by releasing Zn
inflammatory modulation by homogeneously doping variable valence Mn ions into its
framework and showed good therapeutic effects on wound healing in bacterial infections in animal models (Fig. 2)[21]. The development of hybrid nano-systems for the
medication-controlled release remains a challenging task. pH-responsive core–shell
nanocomposites were prepared by growing zeolite imidazoline framework-8 (ZIF-8)
on the aggregated surface of self-assembled polymers. The core is a drug reservoir,
and the shell layer is a gateway to prevent premature drug release. Under excitation
conditions, the polymers exhibited a slow-release behavior for releasing the drug as
compared to the polymers loaded with DOX alone [22].
A drug-release nanocomposite model consists of light-catalyzed TiO
the anti-tumor drug Adriamycin and ZIF-8. The system was shown to release an
amount of drug sufficient to effectively inhibit the IMR-32 neuroblastoma cells used
as a model diseased tissue. This was achieved within 40 min with locally applied UV
irradiation, which is a relatively short period of time compared to the release duration of systems without photocatalysts, which typically take from a couple of hours
to a couple of days [23]. A porous nanocomposite with magnetic and pH response
was produced by grafting of b-cyclodextrin on the surface of Fe
@silica@MIL-
3O4
100(Fe). Temperature and pH effects on the adhesion and release behaviors of the
prepared nanocomposite on cefadroxil showed the greatest amount of absorption
was observed at room temperature, and the release was rapidly at high temperature
[24]. Other MOF-based polymer nanocomposite films were synthesized by using
Zr-based UiO-67 as MOF and PU as polymer matrix. The UiO-67@PU nanocomposites showed prolonged release of bromamine (up to 14 days) [25]. Cerium oxide
composites were incorporated into tricarboxylic acid copper-based metal–organic
skeletons using a precipitation method. The synthesized Cu-MOF/CeO
posites were characterized by various analytical methods to explain their structure,
morphology, and thermal behavior. The concentration of 97.9 mg/ml resulted in a
50% cell mortality rate, low cytotoxicity, and good biocompatibility [26].
2+
nanotubes,
2
nanocom-
2
and
Соседние файлы в папке Библиотека им академика М.И. Перельмана
